Sen. Laura Ellman supports HB4327 to authorize audit of 340B drug program

During the 104th General Assembly on May 31, 2026, Sen. Laura Ellman (D-21st) cast a Yes vote for HB4327, which seeks an audit of participation in the 340B Drug Discount Program. The Illinois Senate passed the legislation unanimously, 57-0.

The legislation summary reads: "AUDITOR GENERAL-340B AUDIT."

The summary provided here reflects the actual bill language and includes clarifications to help explain its intent.

HB4327 instructs the Illinois auditor general to promptly initiate a thorough review of how the state’s 340B covered entities engage with the federal 340B Drug Discount Program. The examination will look at areas such as profits made from 340B drugs, third-party administrator spending, payments to pharmacy benefit managers and contract pharmacies, drug ownership at contract pharmacy locations, average price markups, and the frequency with which savings from discounts are given to at-risk patients at the point of sale. The auditor general is required to deliver findings and recommendations to the General Assembly.

HB4327 was recorded as 'Third Reading - Passed'.

Ellman earned a bachelor’s of science from Grinnell College in 1987.

A Democrat, Ellman began serving as Illinois State Senator for the 21st District in 2019, succeeding former state senator Michael Connelly.

Legislation in Illinois follows a multi-step process that starts with introduction in either the House or Senate, proceeds through committee consideration, floor debate, and votes in both chambers before reaching the governor for signature or veto. The General Assembly conducts business on a biennial cycle, introducing thousands of bills each session; only a small percentage complete the process to become law.